Journals / MN Kardiyoloji / 2021 / Cilt: 28 - Sayı: 4

Upper Gastrointestinal Bleeding Due to “Dieulafoy Lesion” Under Tirofiban Infusion After Complex Percutaneous Coronary Intervention and Its Management

Kompleks Perkütan Koroner Girişim Sonrası Tirofiban İnfüzyonu Altında “Dieulafoy Lezyonu”na Bağlı Üst Gastrointestinal Kanama ve Yönetimi

Pages
246–249
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report, we aim to draw attention to the diagnosis and management of a rarely encountered Dieulafoy lesion in the gastric corpus which complicated the course of a complex coronary intervention.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Upon refusal of coronary artery bypass surgery, a 76 year‐old man underwent a high‐risk percutaneous coronary intervention and was given tirofiban infusion during the procudure and continued afterwards.
📊
Key Findings & Data:He developed hematemesis 4 hours after the infusion was started.
💡
Conclusion & Impact:In this case report, we aim to draw attention to the diagnosis and management of a rarely encountered Dieulafoy lesion in the gastric corpus which complicated the course of a complex coronary intervention.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Upon refusal of coronary artery bypass surgery, a 76 year‐old man underwent a high‐risk percutaneous coronary intervention and was given tirofiban infusion during the procudure and continued afterwards. He developed hematemesis 4 hours after the infusion was started. In this case report, we aim to draw attention to the diagnosis and management of a rarely encountered Dieulafoy lesion in the gastric corpus which complicated the course of a complex coronary intervention.

Özet

Koroner baypas cerrahisini kabul etmeyen 76 yaşında erkek hastaya, yüksek riskli perkütan girişim sırasında ve sonrasında tirofiban infüzyonu verilmiştir. Tirofiban infüzyonunun dördüncü saatinde hastada hematemez gelişmiştir. Bu vaka raporunda, yüksek riskli koroner girişim sonrası mide korpusunda tespit edilmiş nadiren karşılaşılan Dieulafoy lezyonunun tanısına ve tedavisine dikkat çekmek istedik

🔖

Cite This Article

ÇAKIR, B., ARIKAN, M. E., ÖSKEN, A., DAYI, Ş. Ü. (2021). Upper Gastrointestinal Bleeding Due to “Dieulafoy Lesion” Under Tirofiban Infusion After Complex Percutaneous Coronary Intervention and Its Management. MN Kardiyoloji, Cilt: 28 - Sayı: 4, 246–249. https://ajindex.com/articles/399919

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...